Inovio

548 articles about Inovio

• Inovio Pharmaceuticals (Formerly Known as Inovio Biomedical Corporation) Closes $24.3 Million Registered Offering

  1/28/2011

• Inovio Pharmaceuticals (Formerly Known as Inovio Biomedical Corporation) Closes $24.3 Million Registered Offering

  1/28/2011

• Inovio Pharmaceuticals (Formerly Known as Inovio Biomedical Corporation)' Minimally Invasive Intradermal Electroporation Technology Showcased at Vaccine Forum

  1/26/2011

• Inovio Pharmaceuticals (Formerly Known as Inovio Biomedical Corporation) to Net $23M from Stock Offering

  1/25/2011

• Inovio Pharmaceuticals (Formerly Known as Inovio Biomedical Corporation) to Present at Phacilitate Vaccine Forum Washington 2011

  1/20/2011

• Preclinical Efficacy of Inovio Pharmaceuticals (Formerly Known as Inovio Biomedical Corporation)'s Chikungunya DNA Vaccine Featured in PLoS Neglected Tropical Diseases

  1/12/2011

• Inovio Pharmaceuticals (Formerly Known as Inovio Biomedical Corporation)'s Novel DNA Vaccine for Clade C HIV Achieves Immune Responses and Protection in Non-Human Primates

  1/10/2011

• Preclinical Efficacy of Inovio Pharmaceuticals (Formerly Known as Inovio Biomedical Corporation)' Smallpox DNA Vaccine Featured in The Journal of Infectious Diseases

  12/7/2010

• Inovio Pharmaceuticals (Formerly Known as Inovio Biomedical Corporation) Reports Third Quarter 2010 Financial Results

  11/15/2010

• Inovio Pharmaceuticals (Formerly Known as Inovio Biomedical Corporation) HIV Study Update to be Presented at HVTN Conference

  11/12/2010

• Inovio Pharmaceuticals (Formerly Known as Inovio Biomedical Corporation) Receives $733,438 Grant Under the Patient Protection and Affordable Care Program

  11/2/2010

• Inovio Pharmaceuticals (Formerly Known as Inovio Biomedical Corporation) to Present at Investor Conferences In New York and Miami

  10/28/2010

• Inovio Pharmaceuticals (Formerly Known as Inovio Biomedical Corporation) to Present at Investor Conferences In New York and Miami

  10/28/2010

• Inovio Pharmaceuticals (Formerly Known as Inovio Biomedical Corporation) Minimally-Invasive DNA Vaccine Delivery Device Featured in the Journal Gene Therapy

  10/25/2010

• Inovio Pharmaceuticals (Formerly Known as Inovio Biomedical Corporation) to Present at Global Vaccine Forums

  10/22/2010

• Inovio Pharmaceuticals (Formerly Known as Inovio Biomedical Corporation) Chief Medical Officer to Present at Cancer Immunotherapy Conference

  10/15/2010

• Scientific Paper on Inovio Pharmaceuticals (Formerly Known as Inovio Biomedical Corporation) SynCon(TM) DNA Vaccines and Intradermal DNA Delivery Technology One of Most Cited Articles in the Journal Vaccine

  10/14/2010

• Inovio Pharmaceuticals (Formerly Known as Inovio Biomedical Corporation) SynCon(TM) Universal Influenza DNA Vaccine Technology Recognized with National Institutes of Health (NIH) Director's Transformative Research Award

  9/30/2010

• Inovio Pharmaceuticals (Formerly Known as Inovio Biomedical Corporation)' HIV DNA Vaccine/Electroporation Delivery Technology Selected for National Institutes of Health (NIH)-Sponsored US Army Human Clinical Trial

  9/28/2010

• Inovio Pharmaceuticals (Formerly Known as Inovio Biomedical Corporation)' Chief Executive Named Life Sciences CEO of the Year by the Philadelphia Business Journal

  9/28/2010